India’s five-year breast cancer survival rate for women diagnosed between 2017 and 2021 is 65.7%, according to the first country-wise survival estimates published by the World Health Organization (WHO) in Nature Medicine. This figure trails the global median of 77.8% and the 87.3% survival rate seen in high-income countries.
The Survival Gap Between Income Levels
The WHO report reveals a stark divide in outcomes based on national wealth and healthcare infrastructure. Survival rates correlate directly with a country’s income bracket, reflecting disparate access to early detection and specialized treatment.
- High-income countries: 87.3% survival
- Upper-middle-income countries: 78.7% survival
- Lower-middle-income countries: 60.1% survival
- Low-income countries: 41.9% survival
Breast cancer is now the most common cancer among women in 158 countries. In 2024, the disease caused an estimated 6.9 lakh deaths globally, with nearly 70% of those deaths occurring in low- and middle-income countries, according to the WHO.
India’s Progress and Persistent Barriers
While the current 65.7% survival rate highlights a gap, data shows a steady upward trend in India. A 2024 National Cancer Registry Programme study found that five-year survival rates rose from a range of 31-54% for women diagnosed in the 1990s to 66.4% for those diagnosed between 2012 and 2015.
Abhishek Shankar, an assistant professor of radiation oncology at AIIMS, states that India’s survival rate reflects gaps across the entire care continuum. He notes that while community-based screening and the Ayushman Bharat-PMJAY scheme have improved outcomes, many women still present with advanced-stage disease.
According to Shankar, several factors contribute to these delays:
- Low public awareness and social stigma.
- Financial barriers to care.
- Significant disparities in access to pathology, imaging, and radiotherapy between urban and rural areas.
WHO Global Breast Cancer Initiative Goals
The WHO estimates serve as a baseline for the Global Breast Cancer Initiative. This program targets a 2.5% annual reduction in premature breast cancer mortality, with the goal of saving 2.5 million lives by 2040.
The WHO asserts that survival depends heavily on timely access to three critical interventions: surgery, radiotherapy, and cancer medicines. To calculate these estimates, the WHO used survival data from cancer registries in 67 countries and applied statistical modeling for others, factoring in mammography capacity and overall adult mortality.
Comparing Global Regional Survival Rates
| WHO Region/Category | 5-Year Survival Rate |
|---|---|
| Americas | 88.5% |
| European Region | 84% |
| High-Income Countries | 87.3% |
| India (2017-2021) | 65.7% |
Frequently Asked Questions
What is the five-year survival rate for breast cancer in India?
According to the WHO, the estimated five-year survival rate for women diagnosed in India between 2017 and 2021 is 65.7%.
Why is there a difference in survival rates between countries?
The WHO attributes these disparities to differences in early detection, timely diagnosis, and access to essential treatments like surgery and radiotherapy.
What is the goal of the WHO Global Breast Cancer Initiative?
The initiative aims to reduce premature breast cancer mortality by 2.5% every year to save 2.5 million lives by 2040.
Does early diagnosis actually improve survival?
Yes. The WHO identifies the stage at diagnosis as one of the strongest predictors of survival.
To learn more about cancer prevention and screening, visit the World Health Organization official portal.
Join the Conversation: Do you think current public health campaigns are doing enough to tackle the stigma surrounding cancer screenings in rural areas? Share your thoughts in the comments below or subscribe to our newsletter for the latest health updates.
Related reading